Altasciences Capabilities Update August 2026: Oral Solid Dose Formulation

This presentation traces the journey from molecule to medicine, connecting pharmaceutical development with everyday clinical and pharmacy practice. Our experts distinguish drug substance from drug product and explore how different molecular modalities—including small molecules, peptides, biologics, and cell therapies—require distinct formulation and dosage form strategies.

Central to this discussion is the patient-centric Quality Target Product Profile (QTPP), the foundation of Altasciences’ Quality by Design, which aligns patient needs, clinical requirements, and regulatory expectations. Using examples such as insulin pens and extended-release tablets, we illustrate how QTPPs guide the development of safe, effective, and user-friendly medicines. We also examine how artificial intelligence (AI) and automation are accelerating smarter, more efficient, and increasingly patient-focused drug development.